| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | +15.5% | +8.4% |
| R&D Expense | $6.4M | -13.8% | -33.8% |
| SG&A Expense | $3.7M | +3.6% | -2.7% |
| Operating Income | -$6.9M | +16.1% | +34.5% |
| Net Income | -$7.7M | +10.1% | +23.4% |
| EPS (Basic) | -$0.49 | +27.9% | +71.2% |
| EPS (Diluted) | -$0.49 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.1M | -10.7% | -56.6% |
| Accounts Receivable | $3.2M | +17.8% | +8.9% |
| Current Assets | $13.9M | -3.6% | -48.4% |
| Total Assets | $27.6M | -5.4% | -34.9% |
| Current Liabilities | $19.9M | +2.8% | -9.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.8M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $9.9M | — | — |
| +27.9% |
| +71.2% |
| $42.3M |
| -2.1% |
| -17.3% |
| Stockholders' Equity | -$14.7M | -5.0% | -68.2% |